Methods of enhancing mucosal hydration and mucosal clearance...

Details Methods of enhancing mucosal hydration and mucosal clearance... Methods of enhancing mucosal hydration and mucosal clearance...

2007-09-07

2011-11-15

Henley, III, Raymond (Department: 1629)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S255060

Reexamination Certificate

active

08058278

ABSTRACT:
The present invention relates to methods and compositions for treating diseases ameliorated by increased mucociliary clearance and mucosal hydration by administering an effective amount of a sodium channel blocker as defined herein and an osmolyte to a subject to a subject in need of increased mucociliary clearance and mucosal hydration.

REFERENCES:
patent: 4501729 (1985-02-01), Boucher et al.
patent: 5656256 (1997-08-01), Boucher et al.
patent: 5725842 (1998-03-01), Boucher, Jr. et al.
patent: 5817028 (1998-10-01), Anderson
patent: 5876700 (1999-03-01), Boucher, Jr. et al.
patent: 6264975 (2001-07-01), Boucher, Jr.
patent: 6475509 (2002-11-01), Boucher, Jr.
patent: 6607741 (2003-08-01), Boucher, Jr.
patent: 6613345 (2003-09-01), Boucher, Jr.
patent: 6753164 (2004-06-01), Ni et al.
patent: 6858614 (2005-02-01), Johnson
patent: 6858615 (2005-02-01), Johnson
patent: 6903105 (2005-06-01), Johnson
patent: 6926911 (2005-08-01), Boucher, Jr.
patent: 6995160 (2006-02-01), Johnson
patent: 7026325 (2006-04-01), Johnson
patent: 7030117 (2006-04-01), Johnson
patent: 7056524 (2006-06-01), Boucher, Jr.
patent: 7064129 (2006-06-01), Johnson et al.
patent: 7186833 (2007-03-01), Johnson
patent: 7189719 (2007-03-01), Johnson
patent: 7192958 (2007-03-01), Johnson
patent: 7192959 (2007-03-01), Johnson
patent: 7192960 (2007-03-01), Johnson
patent: 7241766 (2007-07-01), Johnson
patent: 7247636 (2007-07-01), Johnson
patent: 7247637 (2007-07-01), Johnson et al.
patent: 2004/0198747 (2004-10-01), Johnson
patent: 2004/0198749 (2004-10-01), Johnson
patent: 2005/0059676 (2005-03-01), Johnson
patent: 2005/0080092 (2005-04-01), Johnson
patent: 2005/0080093 (2005-04-01), Johnson et al.
patent: 2005/0090505 (2005-04-01), Johnson et al.
patent: 2005/0228182 (2005-10-01), Johnson et al.
patent: 2006/0040954 (2006-02-01), Johnson
patent: 2006/0052394 (2006-03-01), Johnson et al.
patent: 2006/0052395 (2006-03-01), Johnson et al.
patent: 2006/0063780 (2006-03-01), Johnson
patent: 2006/0142306 (2006-06-01), Johnson
patent: 2006/0142581 (2006-06-01), Johnson
patent: 2006/0205738 (2006-09-01), Johnson et al.
patent: 2007/0032509 (2007-02-01), Johnson et al.
patent: WO-03/070182 (2003-08-01), None
patent: WO-03070182 (2003-08-01), None
patent: WO-2005/044180 (2005-05-01), None
Zhou Z. et al., Preventive but not late amiloride . . . Am J Respir Crit Care Med. Dec. 15, 2008;178(12):1245-56.
Hirsh AJ,et al., Pharmacological Properties of N-(3,5-diamino-6-chloro . . . J Pharmacol Exp Ther. Apr. 2008;325(1):77-88.
Hirsh AJ, et al., Design, Synthesis, and Structure-activity relationships of . . . J Med Chem. Jul. 13, 2006;49(14):4098-115.
Donaldson SH, Mucus Clearance and Lung Function in CF . . . N Engl J Med. Jan. 19, 2006;354(3):241-50.
Elkins MR, et al., A controlled trial of long-term inhaled hypertonic saline . . . N Engl J Med. Jan. 19, 2006;354(3):229-40.
Hirsh AJ, et al., Evaluation of Second Generation Amiloride . . . J Pharmacol Exp Ther. Dec. 2004;311(3):929-38. Epub Jul. 23, 2004.
Sood N, et al., Increasing concentration of inhaled saline with or without . . . Am J Respir Grit Care Med. Jan. 15, 2003;167(2):158-63.
Tarran R., et al., The CF Salt Controvery: in vivo observations . . . Mol Cell. Jul. 2001;8(1):149-58.
Hoffman T, et al., Effects of Topically Delivered Benzamil and Amiloride . . . Am J Respir Crit Care Med. Jun. 1998;157(6 Pt 1):1844-9.
Jones KM, et al., Pharmacokinetics of Amiloride After Inhalation . . . Pharmacotherapy. Mar.-Apr. 1997;17(2):263-70.
Olivier KN, et al., Acute Safety and Effects on Mucociliary . . . Am J Respir Crit Care Med. Jul. 1996;154(1):217-23.
Bennett WD, et al., Effect of Uridine 5′-Triphosphate Plus Amiloride . . . Am J Respir Crit Care Med. Jun. 1996;153(6 Pt 1):1796-801.
Tomkiewicz RP, et al., Amiloride Inhalation Therapy in CF . . . Am Rev Respir Dis. Oct. 1993;148(4 Pt 1):1002-7.
Knowles MR, et al., Aerosolized Amiloride as Treatment of CF . . . Adv Exp Med Biol. 1991;290:119-28; discussion 129-32.
Knowles MR, et al., A Pilot Study of Aerosolized Amiloride for the . . . N Engl J Med. Apr. 26, 1990;322(17):1189-94.
Mentz WM, et al., Deposition, Clearance and Effects of Aerosolized . . . Am Rev Respir Dis. Nov. 1986;134(5):938-43.
Gowen CW, et al., Increased Nasal Potential Difference and Amiloride . . . J Pediatr. Apr. 1986;108(4):517-21.
Clunes MT et al., Front-runners for Pharmacotherapeutic . . . Curr Opin Pharmacol. Jun. 2008;8(3):292-9.
Tarran R., et al., Rationale for Hypertonic Saline Therapy for CF Lung . . . Semin Respir Crit Care Med. Jun. 2007;28(3):295-302.
Boucher RC. Cystic Fibrosis: A disease of vulnerability to airway surface . . . Trends Mol Med. Jun. 2007;13(6):231-40.
Thelin WR, et al., The Epithelium as a Target for Therapy in CF Curr Opin Pharmacol. Jun. 2007;7(3):290-5.
Boucher RC, Evidence for Airway Surface Dehydration as the Initiating . . . J Intern Med. Jan. 2007;261(1):5-16.
Boucher RC, Airway Surface Dehydration in CF: Pathogenesis . . . Annu Rev Med. 2007;58:157-70.
Cline D, et a., Predicting the Quality of Powders for Inhalation . . . Pharma Res. 2002; 19(9):1274-1277.
Wark P et al., Nebulized Hypertonic Saline for Cystic Fibrosis the Cochrne Collaboration, The Cochrane Library 2008 4:1-35.
U.S. Appl. No. 60/495,725, filed Aug. 18, 2003, Johnson.
U.S. Appl. No. 60/495,720, filed Aug. 18, 2003, Johnson.
U.S. Appl. No. 60/495,712, filed Aug. 18, 2003, Johnson.
U.S. Appl. No. 60/602,312, filed Aug. 18, 2004, Johnson.
U.S. Appl. No. 60/602,327, filed Aug. 18, 2004, Johnson.
U.S. Appl. No. 60/812,091, filed Jun. 9, 2006, Johnson.
U.S. Appl. No. 60/812,077, filed Jun. 9, 2006, Johnson, et al.
U.S. Appl. No. 60/812,078, filed Jun. 9, 2006, Johnson.
U.S. Appl. No. 60/842,669, filed Sep. 7, 2006, Johnson, et al.
U.S. Appl. No. 60/842,963, filed Sep. 8, 2006, Johnson, et al.
U.S. Appl. No. 60/845,171, filed Sep. 18, 2006, Johnson, et al.
U.S. Appl. No. 60/909,818, filed Apr. 3, 2007, Johnson, et al.
U.S. Appl. No. 60/978,887, filed Oct. 10, 2007, Boucher, et al.
U.S. Appl. No. 60/978,874, filed Oct. 10, 2007, Boucher, et al.
U.S. Appl. No. 60/987,663, filed Nov. 13, 2007, Johnson, et al.
U.S. Appl. No. 61/013,387, filed Dec. 13, 2007, Johnson, et al.
U.S. Appl. No. 61/030,313, filed Feb. 21, 2008, Johnson.
U.S. Appl. No. 61/031,466, filed Feb. 26, 2008, Johnson.
U.S. Appl. No. 12/171,814, filed Jul. 11, 2008, Johnson. et al.
U.S. Appl. No. 12/171,867, filed Jul. 11, 2008, Johnson. et al.
U.S. Appl. No. 12/171,897, filed Jul. 11, 2008, Johnson. et al.
U.S. Appl. No. 12/190,022, filed Aug. 12, 2008, Johnson.
U.S. Appl. No. 61/079,989, filed Jul. 11, 2008, Boucher, et al.
U.S. Appl. No. 12/179,353, filed Jul. 24, 2008, Johnson.
U.S. Appl. No. 10/920,527, filed Aug. 18, 2004, Hopkins.
U.S. Appl. No. 11/573,693, filed Feb. 14, 2007, Johnson.
U.S. Appl. No. 11/573,413, filed Feb. 8, 2007, Johnson.
U.S. Appl. No. 11/573,421, filed Feb. 8, 2007, Johnson.
U.S. Appl. No. 11/695,936, filed Apr. 3, 2007, Johnson.
U.S. Appl. No. 11/696,003, filed Apr. 3, 2007, Johnson.
U.S. Appl. No. 11/852,003, filed Sep. 7, 2007, Johnson, et al.
U.S. Appl. No. 11/851,803, filed Sep. 7, 2007, Johnson, et al.
U.S. Appl. No. 11/960,989, filed Dec. 20, 2007, Johnson, et al.
U.S. Appl. No. 11/950,674, filed Dec. 5, 2007, Johnson, et al.
U.S. Appl. No. 11/835,902, filed Aug. 8, 2007, Johnson, et al.
U.S. Appl. No. 12/249,175, filed Oct. 10, 2008, Boucher, et al.
U.S. Appl. No. 12/304,006, filed Dec. 9, 2008, Johnson, et al.
U.S. Appl. No. 12/304,042, filed Dec. 9, 2008, Johnson.
U.S. Appl. No. 12/304,040, filed Dec. 9, 2008, Johnson.
U.S. Appl. No. 12/049,946, filed Mar. 17, 2008, Johnson, et al.
U.S. Appl. No. 12/049,968, filed Mar. 17, 2008, Johnson, et al.
U.S. Appl. No. 12/049,894, filed Mar. 17, 2008, Johnson, et al.
U.S. Appl. No. 12/050,010, filed Mar. 17, 2008, Johnson.
U.S. Appl. No. 12/049,993, filed Mar. 17, 2008, Johnson.
U.S. Appl. No. 12/050,019, filed Mar. 17, 2008, Johnson.
U.S. Appl. No. 12/061,837, filed Apr. 3, 2008, Johnson, et al.
U.S. Appl. No. 12/061,864, filed Apr. 3, 2008, Johnson, et al.
U.S. Appl. No. 12/098,581, filed Apr. 7, 2008, Johnson.
Supp

Affiliated with

Also associated with

Rating

Methods of enhancing mucosal hydration and mucosal clearance... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of enhancing mucosal hydration and mucosal clearance..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of enhancing mucosal hydration and mucosal clearance... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4269862